Xiang YZ - Search Results

1

A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials.

Xiang YZ, Shang HC, Gao XM, Zhang BL. Xiang YZ, et al. Phytother Res. 2008 Jul;22(7):851-8. doi: 10.1002/ptr.2384. Phytother Res. 2008. PMID: 18567057 Review.

2

Compound Salvia droplet pill, a traditional Chinese medicine, for the treatment of unstable angina pectoris: a systematic review.

Zhang JH, Shang HC, Gao XM, Zhang BL, Xiang YZ, Cao HB, Ren M, Wang H. Zhang JH, et al. Among authors: xiang yz. Med Sci Monit. 2008 Jan;14(1):RA1-7. Med Sci Monit. 2008. PMID: 18160949 Review.

3

Three therapeutic tendencies for secondary prevention of myocardial infarction and possible role of Chinese traditional patent medicine: viewpoint of evidence-based medicine.

Shang H, Chen J, Zhang J, Xiang Y, Cao H, Ren M, Wang H, Xu H, Li J, Liu D, Hu J, Wu C, Jing L, Zhang B. Shang H, et al. J Evid Based Med. 2009 May;2(2):84-91. doi: 10.1111/j.1756-5391.2009.01004.x. J Evid Based Med. 2009. PMID: 21348994 Review.

4

[Administration and quality control of large-scale clinical trials of traditional Chinese medicine].

Shang HC, Zhang JH, Dai GH, Cao HB, Ren M, Xiang YZ, Wang Y, Zhang BL, Li YP. Shang HC, et al. Among authors: xiang yz. Zhong Xi Yi Jie He Xue Bao. 2007 Jan;5(1):1-4. doi: 10.3736/jcim20070101. Zhong Xi Yi Jie He Xue Bao. 2007. PMID: 17214927 Chinese.

5

Case recruitment in large-scale clinical trials of traditional Chinese medicine.

Cao HB, Shang HC, Ren M, Zhang JH, Gao X, Xiang YZ, Dai GH, Wang Y, Gao XM, Zhang BL. Cao HB, et al. Among authors: xiang yz. Zhong Xi Yi Jie He Xue Bao. 2007 May;5(3):243-6. doi: 10.3736/jcim20070303. Zhong Xi Yi Jie He Xue Bao. 2007. PMID: 17498480

6

Strategies for antiplatelet targets and agents.

Xiang YZ, Kang LY, Gao XM, Shang HC, Zhang JH, Zhang BL. Xiang YZ, et al. Thromb Res. 2008;123(1):35-49. doi: 10.1016/j.thromres.2008.05.003. Epub 2008 Jun 20. Thromb Res. 2008. PMID: 18571699 Review.

7

Platelet activation, and antiplatelet targets and agents: current and novel strategies.

Xiang YZ, Xia Y, Gao XM, Shang HC, Kang LY, Zhang BL. Xiang YZ, et al. Drugs. 2008;68(12):1647-64. doi: 10.2165/00003495-200868120-00004. Drugs. 2008. PMID: 18681489 Review.

8

[Analysis of factors affecting the progression of visual field defects in patients with myopia and primary open-angle glaucoma].

Huang J, Ye LT, Luo N, Cheng L, Xiang YZ, Huang JJ. Huang J, et al. Among authors: xiang yz. Zhonghua Yan Ke Za Zhi. 2024 Sep 11;60(9):736-745. doi: 10.3760/cma.j.cn112142-20240424-00191. Zhonghua Yan Ke Za Zhi. 2024. PMID: 39267552 Chinese.

9

A novel variant (p.A524P) in Spastin is responsible for a Chinese family with hereditary spastic paraplegia.

Jin YH, Xiang YZ, Zhao MF, Liu YH, Fan LL, Li XC. Jin YH, et al. Among authors: xiang yz. Mol Biol Rep. 2024 Sep 4;51(1):951. doi: 10.1007/s11033-024-09880-0. Mol Biol Rep. 2024. PMID: 39230614

10

Endosymbionts of citrus leafminer Phyllocnistis citrella Stainton among different citrus orchards in China.

Liu HQ, Li HJ, Pan Q, Xiang YZ. Liu HQ, et al. Among authors: xiang yz. Sci Data. 2024 May 22;11(1):519. doi: 10.1038/s41597-024-03372-3. Sci Data. 2024. PMID: 38778070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters